Machine-Learning-Based Radiomics MRI Model for Survival Prediction of Recurrent Glioblastomas Treated with Bevacizumab

Anti-angiogenic therapy with bevacizumab is a widely used therapeutic option for recurrent glioblastoma (GBM). Nevertheless, the therapeutic response remains highly heterogeneous among GBM patients with discordant outcomes. Recent data have shown that radiomics, an advanced recent imaging analysis m...

Descripción completa

Detalles Bibliográficos
Autores principales: Ammari, Samy, Sallé de Chou, Raoul, Assi, Tarek, Touat, Mehdi, Chouzenoux, Emilie, Quillent, Arnaud, Limkin, Elaine, Dercle, Laurent, Hadchiti, Joya, Elhaik, Mickael, Moalla, Salma, Khettab, Mohamed, Balleyguier, Corinne, Lassau, Nathalie, Dumont, Sarah, Smolenschi, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305059/
https://www.ncbi.nlm.nih.gov/pubmed/34359346
http://dx.doi.org/10.3390/diagnostics11071263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305059/
https://www.ncbi.nlm.nih.gov/pubmed/34359346
http://dx.doi.org/10.3390/diagnostics11071263

Ejemplares similares